Department of Veterinary and Biomedical Sciences and Center for Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, Pennsylvania, USA.
Mol Cell Biol. 2012 Jun;32(11):2065-82. doi: 10.1128/MCB.00092-12. Epub 2012 Apr 2.
The role of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in Harvey sarcoma ras (Hras)-expressing cells was examined. Ligand activation of PPARβ/δ caused a negative selection with respect to cells expressing higher levels of the Hras oncogene by inducing a mitotic block. Mitosis-related genes that are predominantly regulated by E2F were induced to a higher level in HRAS-expressing Pparβ/δ-null keratinocytes compared to HRAS-expressing wild-type keratinocytes. Ligand-activated PPARβ/δ repressed expression of these genes by direct binding with p130/p107, facilitating nuclear translocation and increasing promoter recruitment of p130/p107. These results demonstrate a novel mechanism of PPARβ/δ cross talk with E2F signaling. Since cotreatment with a PPARβ/δ ligand and various mitosis inhibitors increases the efficacy of increasing G₂/M arrest, targeting PPARβ/δ in conjunction with mitosis inhibitors could become a suitable option for development of new multitarget strategies for inhibiting RAS-dependent tumorigenesis.
研究了过氧化物酶体增殖物激活受体β/δ(PPARβ/δ)在 Harvey 肉瘤 Ras(Hras)表达细胞中的作用。PPARβ/δ 的配体激活通过诱导有丝分裂阻断,对表达更高水平 Hras 致癌基因的细胞进行负选择。与表达 HRAS 的野生型角质形成细胞相比,表达 HRAS 的 Pparβ/δ 基因敲除角质形成细胞中 E2F 主要调控的有丝分裂相关基因被诱导到更高水平。配体激活的 PPARβ/δ 通过与 p130/p107 的直接结合来抑制这些基因的表达,促进 p130/p107 的核易位并增加启动子募集。这些结果表明了 PPARβ/δ 与 E2F 信号转导的新型交叉对话机制。由于 PPARβ/δ 配体与各种有丝分裂抑制剂的联合处理增加了增加 G₂/M 阻滞的功效,因此靶向 PPARβ/δ 联合有丝分裂抑制剂可能成为开发抑制 RAS 依赖性肿瘤发生的新多靶点策略的合适选择。